Filing Flows › Sotera Health (SHC) › Q3 2026 › vs Q3 2025
Sotera Health (SHC) Q3 2026 vs Q3 2025 (year over year)
Sotera Health's revenue rose $13.6M (+4%) from $311M in Q3 2025 to $325M in Q3 2026. The biggest changes: Sterigenics +$16.5M (+9%); Nordion −$7.8M (-12%); Nelson Labs +$4.9M (+9%). Gross margin 55.6% against 57.0% (-1.4 pts).
Sotera Health, Q3 2026: revenue $325M (+4% year over year), operating margin 25.8%, net earnings $58.4M, operating cash flow $111M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 55.6% | 57.0% | -1.4 pts |
| Operating margin | 25.8% | 23.4% | +2.3 pts |
| Net margin | 18.0% | 15.5% | +2.4 pts |
| Free cash flow margin | 17.8% | 11.2% | +6.5 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Sterigenics | $209M | $193M | $16.5M | +9% |
| Nelson Labs | $60.6M | $55.7M | $4.9M | +9% |
| Nordion | $55.0M | $62.8M | −$7.8M | -12% |
| Revenue | $325M | $311M | $13.6M | +4% |
| Gross profit | $181M | $178M | $3.2M | +2% |
| Cost of revenue | $144M | $134M | $10.3M | +8% |
| Operating profit | $83.7M | $72.9M | $10.8M | +15% |
| Operating expenses | $97.1M | $105M | −$7.6M | -7% |
| Pre-tax earnings | $83.7M | $72.9M | $10.8M | +15% |
| SG&A | $64.1M | $63.3M | $846K | +1% |
| Other operating costs | $32.9M | $41.3M | −$8.4M | -20% |
| Net earnings | $58.4M | $48.4M | $10.0M | +21% |
| Income tax | $25.3M | $24.5M | $806K | +3% |
| Depreciation & amortization | $32.5M | $28.4M | $4.2M | +15% |
| Share-based compensation | $7.7M | $7.9M | −$218K | -3% |
| Working capital & other | $11.9M | −$13.6M | $25.5M | — |
| Operating cash flow | $111M | $71.2M | $39.4M | +55% |
| Free cash flow (OCF − capex) | $57.7M | $35.0M | $22.7M | +65% |
| Capital expenditures | $52.8M | $36.2M | $16.7M | +46% |
Questions
How much did Sotera Health's revenue grow year over year in Q3 2026?
Sotera Health's revenue rose $13.6M (+4%) from $311M in Q3 2025 to $325M in Q3 2026.
What drove Sotera Health's revenue change in Q3 2026?
Sterigenics +$16.5M (+9%); Nordion −$7.8M (-12%); Nelson Labs +$4.9M (+9%).